Assistant Professor of Urology, Yale Department of Urology
Urology
Dr. Brian M. Shuch, MD
|
|
Give Review
Doctor Brian M. Shuch, MD works in the field of Urology. He attended NYU School of Medicine. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Doctor Brian M. Shuch, MD is also a published doctor. He has 70 paper published. The most recent paper is: Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.
Publications
- Genomic characterization of sarcomatoid transformation in clear cell Renal cell carcinoma.
- Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
- MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors.
- Seminoma in Cryptorchid Testis in Prune Belly Syndrome.
- Testicular Cancer, Version 2.2015.
- Association of Urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes.
- Kidney cancer, version 3.2015.
- Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity.
- Chronic Kidney Disease and Risk of Renal Cell Carcinoma: Differences by Race.
- PAX-8 expression in Renal tumours and distant sites: A useful marker of primary and metastatic Renal cell carcinoma?
- The somatic genomic landscape of chromophobe Renal cell carcinoma.
- Vascular Endothelial Growth Factor Receptor-Targeted Therapy in Succinate Dehydrogenase C Kidney Cancer.
- Clinical management of Renal cell carcinoma with venous tumor thrombus.
- The genetic basis of pheochromocytoma and paraganglioma: implications for management.
- Defining early-onset Kidney cancer: implications for germline and somatic mutation testing and clinical management.
- A nested case-control study of leukocyte mitochondrial DNA copy number and Renal cell carcinoma in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
- Pathologic validation of Renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program.
- MRI characterization of the dynamic effects of 5alpha-reductase inhibitors on Prostate zonal volumes.
- Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades Prostate cancer versus systematic 12-core transrectal ultrasound biopsy.
- Adverse Health Outcomes Associated with Surgical Management of the Small Renal Mass.
- Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with Prostate cancer.
- Germline PTEN Mutation Cowden Syndrome: An Under-Appreciated Form of Hereditary Kidney Cancer.
- Overall survival advantage with partial nephrectomy: A bias of observational data?
- A Prospective Study of Leukocyte Telomere Length and Risk of Renal Cell Carcinoma.
- An investigation of risk factors for Renal cell carcinoma by histologic subtype in two case-control studies.
- AdRenal Nodular Hyperplasia in Hereditary Leiomyomatosis and Renal Cell Cancer.
- Racial disparity in Renal cell carcinoma patient survival according to demographic and clinical characteristics.
- The association between Chronic renal failure and renal cell carcinoma may differ between black and white Americans.
- Succinate dehydrogenase Kidney cancer: an aggressive example of the warburg effect in cancer.
- Impact of pathological tumour characteristics in patients with sarcomatoid Renal cell carcinoma.
- The surgical approach to multifocal Renal cancers: hereditary syndromes, ipsilateral multifocality, and bilateral tumors.
- Targeting the mTOR pathway in Chromophobe Kidney Cancer.
- Prognostic factors in Renal cell carcinoma.
- Multivariate analysis of the factors involved in loss of Renal differential function after laparoscopic partial nephrectomy: a role for warm ischemia time.
- Repeat partial nephrectomy: surgical, functional and oncological outcomes.
- The chromophobe tumor grading system is the preferred grading scheme for chromophobe Renal cell carcinoma.
- Sarcomatoid Renal cell carcinoma: a comprehensive review of the biology and current treatment strategies.
- Racial disparity of epidermal growth factor receptor expression in Prostate cancer.
- Serum levels of shed Her2/neu protein in men with prostate cancer correlate with Disease progression.
- Open partial nephrectomy for the treatment of Renal cell carcinoma.
- PD-L1 Expression in Clear Cell Renal Cell Carcinoma: An Analysis of Nephrectomy and Sites of Metastases.
- Metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis Renal cell carcinoma.
- Prognostic factors for Renal cell carcinoma with tumor thrombus extension.
- Neoadjuvant targeted therapy and advanced Kidney cancer: observations and implications for a new treatment paradigm.
- Carbonic anhydrase IX and Renal cell carcinoma: prognosis, response to systemic therapy, and future vaccine strategies.
- Re: efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe Renal cell carcinoma.
- Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance.
- The staging of Renal cell carcinoma.
- Brain metastasis from Renal cell carcinoma: presentation, recurrence, and survival.
- Surveillance for Renal cell carcinoma: why and how? When and how often?
- Cancer-specific survival outcomes among patients treated during the cytokine era of Kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies.
- Intraoperative thrombus embolization during nephrectomy and tumor thrombectomy: critical analysis of the University of California-Los Angeles experience.
- Cytogenetic profile predicts prognosis of patients with clear cell Renal cell carcinoma.
- Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary Renal cell carcinoma.
- Presence of tumor necrosis is not a significant predictor of survival in clear cell Renal cell carcinoma: higher prognostic accuracy of extent based rather than presen...
- Molecular signatures of localized clear cell Renal cell carcinoma to predict disease-free survival after nephrectomy.
- Functional and oncological outcomes of partial nephrectomy of solitary Kidneys.
- CA9 gene: single nucleotide polymorphism predicts metastatic Renal cell carcinoma prognosis.
- Best of the 2009 AUA Annual Meeting: Highlights from the 2009 Annual Meeting of the American Urological Association, April 25-30, 2009, Chicago, IL.
- Cytoreductive nephrectomy for Kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable?
- Histologic evaluation of metastases in Renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy.
- The role of fluorescence in situ hybridization assay for surveillance of non-muscle invasive bladder Cancer.
- Cardiopulmonary bypass and Renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality?
- Chromosome 9p deletions identify an aggressive phenotype of clear cell Renal cell carcinoma.
- Contemporary management of Renal tumors with venous tumor thrombus.
- Immunological therapy in urological malignancy: novel combination strategies.
- Pathological, immunohistochemical and cytogenetic features of papillary Renal cell carcinoma with clear cell features.
- Quality of pathological reporting for Renal cell cancer: implications for systemic therapy, prognostication and surveillance.
- Ultrasound-based combination therapy: potential in urologic Cancer.
Schools
New York University
Procedures Preformed
- Kidney and Ureter Removal
- Renal Transplant and Nephrectomy
Conditions Treated
- Blood in Urine (Hematuria)
- Chronic Kidney Diseases
- Congenital Obstruction of Ureteropelvic Junction
- End-Stage Renal Disease
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
UCLA Medical Center -
NYU School of Medicine
Hospital
-
Yale-New Haven Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1134370422 |
| Last Name Of The Provider | SHUCH |
| First Name Of The Provider | BRIAN |
| View All |
Similar Doctors
|
|
Dr. Adam B. Hittelman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marygrey Maher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter Demir, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bernard Lytton, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Harris E. Foster Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Preston C. Sprenkle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nnenaya Q. Agochukwu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amichai D. Kilchevsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yury Pertsovsky, MD |
|
|
Dr. Sophia D. Delpe, MD |
|
|
Dr. Steven V. Kardos, MD |
|
|
Dr. Hristos Z. Kaimakliotis, MD |